IP Library Granted Patent US 11,286,265
Granted Patent B2
US 11,286,265 · App. 16/866,983 · Granted Mar 29, 2022

Macrocyclic compounds for treating disease

Inventors: Evan W. Rogers (San Diego, CA); Jingrong J. Cui (San Diego, CA); Dayong Zhai (San Diego, CA); Han Zhang (San Diego, CA); Jane Ung (San Diego, CA); Wei Deng (San Diego, CA); Jeffrey Whitten (San Diego, CA)
Assignee: TURNING POINT THERAPEUTICS, INC.
C07D498/22A61P35/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,286,265
App. No.
16/866,983
Granted
Mar 29, 2022
Kind
B2
Abstract

The present disclosure relates to certain macrocyclic derivatives, pharmaceutical compositions containing them, and methods of using them to treat disease, such as cancer.

Claims (21)

1. A compound having structure:

or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1 having structure

or a pharmaceutically acceptable salt thereof.

3. The compound of claim 1 having structure

or a pharmaceutically acceptable salt thereof.

4. The compound of claim 1 having structure

or a pharmaceutically acceptable salt thereof.

5. The compound of claim 1 having structure

or a pharmaceutically acceptable salt thereof.

6. The compound of claim 1 having structure

or a pharmaceutically acceptable salt thereof.

7. A pharmaceutical composition comprising a compound of claim 1 , or a pharmaceutically acceptable salt thereof, and a diluent, carrier or excipient.

8. A method of ameliorating a cancer in a human in need thereof, comprising administering to the human an effective amount of a compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the cancer is selected from thyroid cancer, lung cancer, colon cancer, breast cancer, prostate cancer, hepatocellular carcinoma, and head and neck cancer.

9. The method of claim 8 , wherein the cancer is thyroid cancer.

10. The method of claim 8 , wherein the cancer is lung cancer.

11. The method of claim 8 , wherein the cancer is colon cancer.

12. The method of claim 8 , wherein the cancer is breast cancer.

13. The method of claim 8 , wherein the cancer is prostate cancer.

14. The method of claim 8 , wherein the cancer is hepatocellular carcinoma.

15. The method of claim 8 , wherein the cancer is head and neck cancer.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2022
From: ROGERS, EVAN W.; CUI, JINGRONG J.; ZHAI, DAYONG
To: TP THERAPEUTICS, INC.
Reel/Frame 059685/0909 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2022
From: ROGERS, EVAN W.; CUI, JINGRONG J.; ZHAI, DAYONG; ZHANG, HAN; UNG, JANE; DENG, WEI
To: TP THERAPEUTICS, INC.
Reel/Frame 059686/0003 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2021
From: CUI, JINGRONG JEAN; ROGERS, EVAN W; UNG, JANE; WHITTEN, JEFFREY; ZHAI, DAYONG; DENG, WEI; ZHANG, HAN
To: TP THERAPEUTICS, INC.
Reel/Frame 058137/0532 →
CHANGE OF NAME Recorded Nov 17, 2021
From: TP THERAPEUTICS, INC.
To: TURNING POINT THERAPEUTICS, INC.
Reel/Frame 058171/0081 →
Continuity (6)
Continuation 16777717 · Jan 30, 2020
Continuation PCTUS2018066158 · Dec 18, 2018
Provisional Application 62779283 · Dec 13, 2018
Provisional Application 62727124 · Sep 5, 2018
Provisional Application 62607528 · Dec 19, 2017
Related Publication 20200392160A1 · Dec 17, 2020